{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T14:04:14Z","timestamp":1787321054084,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Patient Rep Outcomes"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Sleep disturbance, pain, and fatigue are key symptoms\/impacts of axial spondyloarthritis (axSpA). Three customized Patient-Reported Outcomes Measurement Information System (PROMIS\n                      <jats:sup>\u00ae<\/jats:sup>\n                      ) Short Forms (Sleep Disturbance, Pain Interference, and Fatigue) have been proposed for use in axSpA to assess these key disease concepts. This study was designed to further understand the patient experience of axSpA and evaluate the content validity of the three customized PROMIS\n                      <jats:sup>\u00ae<\/jats:sup>\n                      Short Forms to support their use in axSpA clinical trials.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Non-interventional, cross-sectional, qualitative (concept elicitation [CE] and cognitive debriefing [CD]) study. Participants took part in 90-min telephone interviews. The CE section used open-ended questions to elicit information about axSpA symptoms and impacts. The CD section involved a \u2018think-aloud\u2019 exercise where participants read out each instruction, item, and response option for the customized PROMIS\n                      <jats:sup>\u00ae<\/jats:sup>\n                      Short Forms and shared their feedback. Participants also discussed the relevance of the items, response options and recall period. Verbatim interview transcripts were subject to thematic and content analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In total, there were 28 participants (non-radiographic axSpA, n\u2009=\u200912; ankylosing spondylitis, n\u2009=\u200916), from the US (n\u2009=\u200920) and Germany (n\u2009=\u20098). Mean age was 52.8\u00a0years, and 57% were male; mean time since diagnosis was 9.5\u00a0years. The CE section identified 12 distinct symptoms that characterized axSpA: pain, sleep problems, fatigue\/tiredness, stiffness, swelling, vision\/eye issues, restricted body movements, headache\/migraine, spasms, change in posture\/stature, balance\/coordination problems, and numbness. Pain, sleep problems, and fatigue\/tiredness were experienced by\u2009\u2265\u200990% of participants, occurring simultaneously and exacerbating one another. Participants reported axSpA impacted their lives across six domains of health-related quality of life (HRQoL): physical functioning (100%), emotional wellbeing (89%), work\/volunteering (79%), social functioning (75%), activities of daily living (61%) and cognitive functioning (54%). Impacts were most frequently associated with pain, stiffness, and fatigue. CD showed the PROMIS\n                      <jats:sup>\u00ae<\/jats:sup>\n                      instruments were conceptually comprehensive and well understood, with all items relevant to\u2009\u2265\u200950% of participants.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Pain, sleep problems and fatigue are pivotal symptoms of axSpA and associated with HRQoL impacts. These results were used to update a conceptual model of axSpA which was originally developed based on a targeted literature review. Interpretability and content validity of the customized PROMIS\n                      <jats:sup>\u00ae<\/jats:sup>\n                      Short Forms were confirmed, with each deemed to adequately assess key impacts associated with axSpA, making them suitable for use in axSpA clinical trials.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41687-023-00575-x","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T14:26:24Z","timestamp":1682000784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Qualitative concept elicitation and cognitive debriefing interviews of symptoms, impacts and selected customized PROMIS\u00ae Short Forms: a study in patients with axial spondyloarthritis"],"prefix":"10.1186","volume":"7","author":[{"given":"Amy","family":"Findley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica M.","family":"Middlehurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe A.","family":"Howse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly J.","family":"Clifford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophi","family":"Tatlock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marguerite G.","family":"Bracher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharm S.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,20]]},"reference":[{"key":"575_CR1","doi-asserted-by":"publisher","first-page":"e547","DOI":"10.1097\/RHU.0000000000001575","volume":"27","author":"JA Walsh","year":"2021","unstructured":"Walsh JA, Magrey M (2021) Clinical manifestations and diagnosis of axial spondyloarthritis. J Clin Rheumatol 27:e547\u2013e560. https:\/\/doi.org\/10.1097\/RHU.0000000000001575","journal-title":"J Clin Rheumatol"},{"key":"575_CR2","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/ard.2009.108233","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, van der Heijde D, Landewe R, Listing J, Akkoc N, Brandt J, Braun J, Chou CT, Collantes-Estevez E, Dougados M, Huang F, Gu J, Khan MA, Kirazli Y, Maksymowych WP, Mielants H, Sorensen IJ, Ozgocmen S, Roussou E, Valle-Onate R, Weber U, Wei J, Sieper J (2009) The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68:777\u2013783. https:\/\/doi.org\/10.1136\/ard.2009.108233","journal-title":"Ann Rheum Dis"},{"key":"575_CR3","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s40744-019-0160-8","volume":"6","author":"JT Rosenbaum","year":"2019","unstructured":"Rosenbaum JT, Pisenti L, Park Y, Howard RA (2019) Insight into the quality of life of patients with ankylosing spondylitis: real-world data from a US-based life impact survey. Rheumatol Ther 6:353\u2013367. https:\/\/doi.org\/10.1007\/s40744-019-0160-8","journal-title":"Rheumatol Ther"},{"key":"575_CR4","first-page":"975","volume":"34","author":"J Sieper","year":"2016","unstructured":"Sieper J, Holbrook T, Black CM, Wood R, Hu X, Kachroo S (2016) Burden of illness associated with non-radiographic axial spondyloarthritis: a multiperspective European cross-sectional observational study. Clin Exp Rheumatol 34:975\u2013983","journal-title":"Clin Exp Rheumatol"},{"key":"575_CR5","doi-asserted-by":"publisher","first-page":"e001108","DOI":"10.1136\/rmdopen-2019-001108","volume":"5","author":"C Lopez-Medina","year":"2019","unstructured":"Lopez-Medina C, Ramiro S, van der Heijde D, Sieper J, Dougados M, Molto A (2019) Characteristics and burden of disease in patients with radiographic and non-radiographic axial Spondyloarthritis: a comparison by systematic literature review and meta-analysis. RMD Open 5:e001108. https:\/\/doi.org\/10.1136\/rmdopen-2019-001108","journal-title":"RMD Open"},{"key":"575_CR6","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s40744-019-00176-5","volume":"6","author":"A Deodhar","year":"2019","unstructured":"Deodhar A, Gensler LS, Magrey M, Walsh JA, Winseck A, Grant D, Mease PJ (2019) Assessing physical activity and sleep in axial spondyloarthritis: measuring the gap. Rheumatol Ther 6:487\u2013501. https:\/\/doi.org\/10.1007\/s40744-019-00176-5","journal-title":"Rheumatol Ther"},{"key":"575_CR7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/RHU.0000000000000589","volume":"23","author":"V Strand","year":"2017","unstructured":"Strand V, Singh JA (2017) Patient burden of axial spondyloarthritis. J Clin Rheumatol 23:383\u2013391. https:\/\/doi.org\/10.1097\/RHU.0000000000000589","journal-title":"J Clin Rheumatol"},{"key":"575_CR8","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.3899\/jrheum.200872","volume":"48","author":"E Mogard","year":"2021","unstructured":"Mogard E, Olofsson T, Bergman S, Bremander A, Kristensen LE, Olsen JK, Wallman JK, Lindqvist E (2021) Chronic pain and assessment of pain sensitivity in patients with axial spondyloarthritis: results from the SPARTAKUS cohort. J Rheumatol 48:1672\u20131679. https:\/\/doi.org\/10.3899\/jrheum.200872","journal-title":"J Rheumatol"},{"key":"575_CR9","doi-asserted-by":"publisher","first-page":"e053958","DOI":"10.1136\/bmjopen-2021-053958","volume":"12","author":"NA Pearson","year":"2022","unstructured":"Pearson NA, Tutton E, Martindale J, Strickland G, Thompson J, Packham JC, Creamer P, Haywood K (2022) Qualitative interview study exploring the patient experience of living with axial spondyloarthritis and fatigue: difficult, demanding and draining. BMJ Open 12:e053958. https:\/\/doi.org\/10.1136\/bmjopen-2021-053958","journal-title":"BMJ Open"},{"key":"575_CR10","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286\u20132291","journal-title":"J Rheumatol"},{"key":"575_CR11","first-page":"2281","volume":"21","author":"A Calin","year":"1994","unstructured":"Calin A, Garrett S, Whitelock H, Kennedy LG, O\u2019Hea J, Mallorie P, Jenkinson T (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281\u20132285","journal-title":"J Rheumatol"},{"key":"575_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1136\/ard.62.1.20","volume":"62","author":"LC Doward","year":"2003","unstructured":"Doward LC, Spoorenberg A, Cook SA, Whalley D, Helliwell PS, Kay LJ, McKenna SP, Tennant A, van der Heijde D, Chamberlain MA (2003) Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis 62:20\u201326. https:\/\/doi.org\/10.1136\/ard.62.1.20","journal-title":"Ann Rheum Dis"},{"key":"575_CR13","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1093\/rheumatology\/kep457","volume":"49","author":"MC Reilly","year":"2010","unstructured":"Reilly MC, Gooch KL, Wong RL, Kupper H, van der Heijde D (2010) Validity, reliability and responsiveness of the Work Productivity and Activity Impairment Questionnaire in ankylosing spondylitis. Rheumatology (Oxford) 49:812\u2013819. https:\/\/doi.org\/10.1093\/rheumatology\/kep457","journal-title":"Rheumatology (Oxford)"},{"key":"575_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4078\/jrd.2020.27.1.22","volume":"27","author":"U Kiltz","year":"2020","unstructured":"Kiltz U, Braun J (2020) Assessments of functioning in patients with axial spondyloarthritis. J Rheum Dis 27:22\u201329. https:\/\/doi.org\/10.4078\/jrd.2020.27.1.22","journal-title":"J Rheum Dis"},{"key":"575_CR15","unstructured":"Food and Drug Administration (2018) Patient-Focused Drug Development Guidance: Methods to Identify What is Important to Patients and Select, Develop or Modify Fit-for-Purpose Clinical Outcome Assessments. https:\/\/www.fda.gov\/drugs\/news-events-human-drugs\/patient-focused-drug-development-guidance-methods-identify-what-important-patients-and-select. Accessed 6 Apr 2023"},{"issue":"Suppl 11","key":"575_CR16","doi-asserted-by":"publisher","first-page":"S486","DOI":"10.1002\/acr.20581","volume":"63","author":"D Khanna","year":"2011","unstructured":"Khanna D, Krishnan E, Dewitt EM, Khanna PP, Spiegel B, Hays RD (2011) The future of measuring patient-reported outcomes in rheumatology: Patient-Reported Outcomes Measurement Information System (PROMIS). Arthritis Care Res (Hoboken) 63(Suppl 11):S486-490. https:\/\/doi.org\/10.1002\/acr.20581","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"575_CR17","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1136\/annrheumdis-2017-eular.1849","volume":"76","author":"V Short","year":"2017","unstructured":"Short V, McBeth J, Druce KL, Moore S, Dixon W, Kyle S, Lunt M, Cordingley L (2017) FRI0105 fluctuating, unpredictable and challenging: how pain, fatigue and sleep disturbance impact quality of life in people with rheumatoid arthritis. Ann Rheum Dis 76:519. https:\/\/doi.org\/10.1136\/annrheumdis-2017-eular.1849","journal-title":"Ann Rheum Dis"},{"key":"575_CR18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s41687-021-00318-w","volume":"5","author":"B Becker","year":"2021","unstructured":"Becker B, Raymond K, Hawkes C, Foster AM, Lovley A, Saucier C, Rizio AA, Bjorner JB, Kosinski M (2021) Qualitative and psychometric approaches to evaluate the PROMIS pain interference and sleep disturbance item banks for use in patients with rheumatoid arthritis. J Patient Rep Outcomes 5:52. https:\/\/doi.org\/10.1186\/s41687-021-00318-w","journal-title":"J Patient Rep Outcomes"},{"key":"575_CR19","doi-asserted-by":"publisher","first-page":"e024338","DOI":"10.1136\/bmjopen-2018-024338","volume":"9","author":"J Primdahl","year":"2019","unstructured":"Primdahl J, Hegelund A, Lorenzen AG, Loeppenthin K, Dures E, Appel Esbensen B (2019) The experience of people with rheumatoid arthritis living with fatigue: a qualitative metasynthesis. BMJ Open 9:e024338. https:\/\/doi.org\/10.1136\/bmjopen-2018-024338","journal-title":"BMJ Open"},{"key":"575_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V (2006) Using thematic analysis in psychology. Qual Res Psychol 3:77\u2013101. https:\/\/doi.org\/10.1191\/1478088706qp063oa","journal-title":"Qual Res Psychol"},{"key":"575_CR21","volume-title":"Cognitive interviewing: a tool for improving questionnaire design","author":"GB Willis","year":"2004","unstructured":"Willis GB (2004) Cognitive interviewing: a tool for improving questionnaire design. SAGE Publications, Inc, Thousand Oaks"},{"key":"575_CR22","unstructured":"ATLAS.ti.Scientific Software Development GmbH (2013) Atlas.ti.software version 7. https:\/\/atlasti.com\/. Accessed 13 Oct 2022"},{"key":"575_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/104973239500500201","volume":"5","author":"JM Morse","year":"1995","unstructured":"Morse JM (1995) The significance of saturation. Qual Health Res 5:147\u2013149. https:\/\/doi.org\/10.1177\/104973239500500201","journal-title":"Qual Health Res"},{"key":"575_CR24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/1525822X05279903","volume":"18","author":"G Guest","year":"2006","unstructured":"Guest G, Bunce A, Johnson L (2006) How many interviews are enough?: an experiment with data saturation and variability. Field Methods 18:59\u201382. https:\/\/doi.org\/10.1177\/1525822X05279903","journal-title":"Field Methods"},{"key":"575_CR25","unstructured":"Food and Drug Administration (2020) Patient-focused drug development: collecting comprehensive and representative input. https:\/\/www.fda.gov\/media\/139088\/download. Accessed 6 Apr 2023."},{"issue":"Suppl 107","key":"575_CR26","first-page":"102","volume":"35","author":"U Kiltz","year":"2017","unstructured":"Kiltz U, Baraliakos X, Regel A, Buhring B, Braun J (2017) Causes of pain in patients with axial spondyloarthritis. Clin Exp Rheumatol 35(Suppl 107):102\u2013107","journal-title":"Clin Exp Rheumatol"},{"key":"575_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/rheumatology\/key079","volume":"57","author":"J Braun","year":"2018","unstructured":"Braun J (2018) Axial spondyloarthritis including ankylosing spondylitis. Rheumatology (Oxford) 57:1\u20133. https:\/\/doi.org\/10.1093\/rheumatology\/key079","journal-title":"Rheumatology (Oxford)"},{"key":"575_CR28","doi-asserted-by":"publisher","first-page":"rky017","DOI":"10.1093\/rap\/rky017","volume":"2","author":"NA Pearson","year":"2018","unstructured":"Pearson NA, Packham JC, Tutton E, Parsons H, Haywood KL (2018) Assessing fatigue in adults with axial spondyloarthritis: a systematic review of the quality and acceptability of patient-reported outcome measures. Rheumatol Adv Pract 2:rky017. https:\/\/doi.org\/10.1093\/rap\/rky017","journal-title":"Rheumatol Adv Pract"},{"key":"575_CR29","doi-asserted-by":"crossref","unstructured":"Lamoureux RE, Shields A, Stokes J, Yaworsky A, Galipeau N. (2015) How many subjects are enough for symptom-focused concept elicitation studies? A retrospective analysis of saturation across twenty-six studies. In: ISPOR 20th annual international meeting research abstracts author index. ISPOR, Philadelphia, PA, USA, 16\u201320 May 2015. Value in Health 18:A33.","DOI":"10.1016\/j.jval.2015.03.198"},{"key":"575_CR30","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1080\/08870440903194015","volume":"25","author":"JJ Francis","year":"2010","unstructured":"Francis JJ, Johnston M, Robertson C, Glidewell L, Entwistle V, Eccles MP, Grimshaw JM (2010) What is an adequate sample size? Operationalising data saturation for theory-based interview studies. Psychol Health 25:1229\u20131245. https:\/\/doi.org\/10.1080\/08870440903194015","journal-title":"Psychol Health"}],"container-title":["Journal of Patient-Reported Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-023-00575-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41687-023-00575-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-023-00575-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T14:36:05Z","timestamp":1682001365000},"score":1,"resource":{"primary":{"URL":"https:\/\/jpro.springeropen.com\/articles\/10.1186\/s41687-023-00575-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,20]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["575"],"URL":"https:\/\/doi.org\/10.1186\/s41687-023-00575-x","relation":{},"ISSN":["2509-8020"],"issn-type":[{"value":"2509-8020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,20]]},"assertion":[{"value":"3 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval (20202526) was sought from a centralized Institutional review board (IRB) in the US (Copernicus IRB), which covered both the US and Germany aspects of this research. The project was conducted according to the principles outlined in the declaration of Helsinki and in line with guidelines related to GCP published by the FDA and EMA, where applicable to non-interventional research. All participants gave informed, written consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants provided consent for their data from this research to be published in the public domain; however, all data included in the manuscript are anonymized so specific participants cannot be identified.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AF, JM, CH, MC, and ST are employees of Adelphi Values, which received funding from GSK for the conduct of this study, although not for manuscript development. WN was an employee of Adelphi Values at the time of study conduct. WHC, MB and DP are employees of and\/or hold stocks\/shares in GSK.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}